Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Microsoft Says It Offered U.S. FTC Consent Decree On Call Of Duty

Legal
News

Microsoft Says It Offered U.S. FTC Consent Decree On Call Of Duty

– Bloomberg News

byBenzinga Newsdesk

December 13, 2022

1 minute read

– Bloomberg News

BlackSky Signs Five-Launch Deal With Rocket Lab To Launch Next-Gen Capabilities And Meet Growing Demand For High-Frequency Monitoring

By Happy Mohamed

August 8, 5:28 PM

Agreement secures ability to commence launch of Gen-3 satellites in 2024 BlackSky Technology Inc. (NYSE:BKSY) and Rocket Lab USA, Inc. (NASDAQ:RKLB) signed an agreement to buy a block of five launches that will increase

BKSY

News

‘JP Morgan Officially Registers Cryptocurrency Trademark for Digital Asset Processing’ -Tesmanian Report

By Benzinga Newsdesk

November 21, 2:53 PM

https://www.tesmanian.com/blogs/tesmanian-blog/jp-morgan-officially-registers-cryptocurrency-trademark-for-digital-asset-transactions

JPM

Citigroup Maintains Buy on Logitech International, Lowers Price Target to $70

By Benzinga Newsdesk

January 25, 12:36 PM

Citigroup analyst Asiya Merchant maintains Logitech International (NASDAQ:LOGI) with a Buy and lowers the price target from $75 to $70.

LOGI

Barclays Maintains Equal-Weight on Editas Medicine, Raises Price Target to $17

By Benzinga Newsdesk

August 4, 7:09 AM

Barclays analyst Gena Wang maintains Editas Medicine (NASDAQ:EDIT) with a Equal-Weight and raises the price target from $16 to $17.

EDIT

Microsoft Says It Offered U.S. FTC Consent Decree On Call Of Duty

Related Posts

BlackSky Signs Five-Launch Deal With Rocket Lab To Launch Next-Gen Capabilities And Meet Growing Demand For High-Frequency Monitoring

‘JP Morgan Officially Registers Cryptocurrency Trademark for Digital Asset Processing’ -Tesmanian Report

Citigroup Maintains Buy on Logitech International, Lowers Price Target to $70

Barclays Maintains Equal-Weight on Editas Medicine, Raises Price Target to $17